title: Technetium-99m-sestamibi uptake in myeloma.
abstract: A number of reports describe how 99mTc-sestamibi detects benign and malignant primary and metastatic tumors. We report abnormal 99mTc-sestamibi uptake in nine sites in a 53-yr-old patient with histologically and biochemically proven IgG kappa-secreting myeloma. The 99mTc-sestamibi study was undertaken for an unrelated hyperparathyroidism.
authors.affiliation: Department of Nuclear Medicine, University of Cape Town, South Africa.
authors.forename: B K
authors.initials: BK
authors.lastname: Adams
authors.forename: A
authors.initials: A
authors.lastname: Fataar
authors.forename: M A
authors.initials: MA
authors.lastname: Nizami
mesh_terms: D005260:Female; D006801:Humans; D006965:Hyperplasia; D007145:Immunoglobulin kappa-Chains / Q000378:metabolism; D008875:Middle Aged; D009101:Multiple Myeloma / Q000000981:diagnostic imaging* / Q000276:immunology; D010280:Parathyroid Glands / Q000000981:diagnostic imaging / Q000473:pathology; D011877:Radionuclide Imaging; D017256:Technetium Tc 99m Sestamibi
chemical_list: D007145:Immunoglobulin kappa-Chains; D017256:Technetium Tc 99m Sestamibi